Philips to incorporate Dana Farber’s clinical pathways to bolster decision support for cancer care

Philips to incorporate Dana Farber's clinical pathways to bolster decision support for cancer care

Royal Philips is poised to implement Medical Pathways from the Boston-based Dana-Farber Most cancers Institute, a number one middle of most cancers analysis and remedy.

Dana-Farber Medical Pathways can be deployed by way of Philips IntelliSpace Oncology, a cloud-based precision drugs platform that gives physicians patient-centric medical resolution assist.

The aim is to assist oncologists shortly determine essentially the most acceptable most cancers remedies, based mostly on the unified view of the affected person throughout diagnostic modalities and the embedded data of Medical Pathways.

Also: Is your hospital ready for the many challenges of precision medicine?

Philips will leverage Dana-Farber Medical Pathways to map most cancers sufferers to the suitable remedy choices through its oncology informatics suite, which integrates radiology, pathology, genomics and EHR information to assist scale precision drugs.

“Each most cancers affected person deserves the absolute best care,” mentioned Dana Farber CEO Laurie Glimcher, MD.

Most cancers drugs is altering quickly, and physicians are tasked with decoding large quantities of latest data generated from publications and medical trials,” Glimcher added.

Philips CEO Frans van Houten added that patient-centric care is crucial to most cancers remedies.

“Leveraging medical data and oncology informatics will assist present docs with the medical resolution they should present the best care, based mostly on sufferers’ genome,” he mentioned.

Twitter: @Bernie_HITNEmail the author: bernie.monegain@himssmedia.com

Be the first to comment on "Philips to incorporate Dana Farber’s clinical pathways to bolster decision support for cancer care"

Leave a comment

Your email address will not be published.


*